Does gabapentin interact with nortriptyline?

Gabapentin and Nortriptyline: No Significant Drug Interaction

Gabapentin and nortriptyline can be safely combined without clinically significant pharmacokinetic or pharmacodynamic interactions. In fact, this combination is therapeutically beneficial and superior to either drug used alone for neuropathic pain.

Evidence from FDA Drug Labeling

The FDA-approved gabapentin prescribing information explicitly addresses drug interactions and does not list nortriptyline or any tricyclic antidepressants as interacting medications 1. The drug label specifically states that gabapentin:

• Does not inhibit major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4) at therapeutic concentrations
• Has minimal drug interactions overall
• Does not undergo hepatic metabolism (eliminating a major source of drug interactions)
• Is primarily renally excreted without involvement of drug transporters that could be affected by other medications

Clinical Evidence Supporting Combination Therapy

The combination of gabapentin and nortriptyline demonstrates synergistic efficacy rather than problematic interactions 2. A landmark randomized controlled trial showed that the nortriptyline-gabapentin combination was superior to either medication administered alone for neuropathic pain, with mean pain scores of 2.3 for combination therapy versus 3.2 for gabapentin alone and 2.9 for nortriptyline alone 3.

Key Clinical Points:

• Both drugs act through different mechanisms: Gabapentin binds voltage-gated calcium channels at the α2-δ subunit, while nortriptyline blocks norepinephrine and serotonin reuptake 2
• The combination requires lower doses of each drug to achieve superior pain relief compared to monotherapy 2
• Additive sedation is the primary concern, not a true drug interaction—both medications can cause dose-dependent dizziness and sedation through their CNS effects 2

Practical Prescribing Considerations

When combining these medications:

• Start with low doses and titrate slowly to minimize additive CNS depression (sedation, dizziness)
• For gabapentin: begin at 100-300 mg at bedtime, increase by 100-300 mg every 1-7 days as tolerated 2
• For nortriptyline: begin at 25 mg at bedtime, increase by 25 mg every 3-7 days as tolerated 2
• Monitor for cumulative sedation, particularly in elderly patients or those with renal impairment (gabapentin requires dose reduction with decreased creatinine clearance)
• The most common adverse effect with combination therapy is dry mouth, which occurs more frequently than with gabapentin alone but is manageable 3

Important Caveats

While there is no pharmacokinetic interaction, the overlapping side effect profiles (particularly CNS depression) can limit tolerability 2, 4. This is not a true drug interaction but rather additive pharmacodynamic effects. The combination may produce higher dropout rates due to side effects compared to monotherapy, though efficacy gains often justify this risk 2.

Bottom line: Gabapentin does not interact with nortriptyline through metabolic pathways or drug transporters. The combination is evidence-based, guideline-supported, and therapeutically advantageous for neuropathic pain, though careful dose titration is essential to manage additive sedation.